Literature DB >> 20232341

Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets.

Manuel Guerreiro1, Il-Kang Na, Anne Letsch, Doreen Haase, Sandra Bauer, Christian Meisel, Andy Roemhild, Petra Reinke, Hans-Dieter Volk, Carmen Scheibenbogen.   

Abstract

EBV infection leads to life-long viral persistence. Although EBV infection can result in chronic disease and malignant transformation, most carriers remain disease-free as a result of effective control by T cells. EBV-specific IFN-gamma-producing T cells could be demonstrated in acute and chronic infection as well as during latency. Recent studies, however, provide evidence that assessing IFN-gamma alone is insufficient to assess the quantity and quality of a T-cell response. Using overlapping peptide pools of latent EBV nuclear antigen 1 and lytic BZLF-1 protein and multicolor flow cytometry, we demonstrate that the majority of ex vivo EBV-reactive T cells in healthy virus carriers are indeed IL-2- and/or TNF-producing memory cells, the latter being significantly more frequent in BM. After in vitro expansion, a substantial number of EBV-specific CD4(+) and CD8(+) T cells retained a CC-chemokine receptor 7 (CCR7)-positive memory phenotype. Based on their cytokine profiles, six different EBV-specific T-cell subsets could be distinguished with TNF-single or TNF/IL-2-double producing cells expressing the highest CCR7 levels resembling early-differentiated memory T cells. Our study delineates the memory T-cell profile of a protective immune response and provides a basis for analyzing T-cell responses in EBV-associated diseases.

Entities:  

Mesh:

Year:  2010        PMID: 20232341     DOI: 10.1002/eji.200940000

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Editorial: T cell memory, bone marrow, and aging: the good news.

Authors:  Rita B Effros
Journal:  J Leukoc Biol       Date:  2012-02       Impact factor: 4.962

2.  Bone marrow vaccination: a novel approach to enhance antigen specific antitumor immunity.

Authors:  Stephanie Fresnay; Xiaoyu Zhang; Scott E Strome; Duane A Sewell
Journal:  Vaccine       Date:  2011-09-25       Impact factor: 3.641

3.  Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.

Authors:  D Cárdenas; G Vélez; A Orfao; M V Herrera; J Solano; M Olaya; A M Uribe; C Saavedra; M Duarte; M Rodríguez; M López; S Fiorentino; S Quijano
Journal:  Clin Exp Immunol       Date:  2015-09-11       Impact factor: 4.330

4.  A Comparison of Immune Functionality in Viral versus Non-Viral CFS Subtypes.

Authors:  Nicole Porter; Athena Lerch; Leonard A Jason; Matthew Sorenson; Mary Ann Fletcher; Joshua Herrington
Journal:  J Behav Neurosci Res       Date:  2010-06-01

5.  Age-associated Epstein-Barr virus-specific T cell responses in seropositive healthy adults.

Authors:  D Cárdenas Sierra; G Vélez Colmenares; A Orfao de Matos; S Fiorentino Gómez; S M Quijano Gómez
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

6.  Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients.

Authors:  Lukas Baitsch; Petra Baumgaertner; Estelle Devêvre; Sunil K Raghav; Amandine Legat; Leticia Barba; Sébastien Wieckowski; Hanifa Bouzourene; Bart Deplancke; Pedro Romero; Nathalie Rufer; Daniel E Speiser
Journal:  J Clin Invest       Date:  2011-05-09       Impact factor: 14.808

7.  Long-term carriers generate Epstein-Barr virus (EBV)-specific CD4(+) and CD8(+) polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins.

Authors:  Raymond J Ning; Xue Q Xu; Kwok H Chan; Alan K S Chiang
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

8.  Editorial: What caused all these troubles, anyway? Epstein-Barr virus in Sjögren's syndrome reevaluated.

Authors:  John B Harley; Erin E Zoller
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

9.  CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques.

Authors:  R M Leskowitz; X Y Zhou; F Villinger; M H Fogg; A Kaur; P M Lieberman; F Wang; H C Ertl
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

10.  T-Lymphocyte Activation Is Correlated With the Presence of Anti-EBV in Patients With Laryngeal Squamous Cell Carcinoma.

Authors:  Janusz Klatka; Anna Hymos; Anna Szkatuła-Łupina; Ewelina Grywalska; Barbara Klatka; Michał Terpiłowski; Andrzej Stepulak
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.